跳至主要内容
临床试验/CTRI/2025/11/097622
CTRI/2025/11/097622尚未招募不适用

Role of Neuromuscular blocking agent Vecuronium in improving the first pass success of intubation in Pediatric Emergency An open label Randomised Controlled Trial

未提供1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年12月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
60
试验地点
1
主要终点
To assess the Role of Neuromuscular Blocking Agent, Vecuronium in improving the first pass success of intubation in Pediatric emergency

研究概览

简要总结

The use of a neuromuscular-blocking during intubation can improve the quality as well as the success rate of tracheal intubation, better hemodynamic stability during induction of anesthesia, lower prevalence of hypoxemia and procedure-related complications

Usage of NMBA was also associated with reduced complications and respiratory arrest or cardiovascular collapse

Studies have shown to improve the odds of improving FPS at intubation with usage of NMBA and better ease of intubation with usage of NMBA in adults and children

However there is no consensus existing regarding the use of NMBA in children so far. Hence we have planned this study to assess the first pass success with NMBA and associated factors which will ease the intubation in children

METHODS OF THE STUDY Children of age group between 1 month to 14 years presenting to Paediatric emergency planned for intubation will be enrolled in the study and they will be allocated to the two groups by computer generated block random allocation after child satisfies the inclusion criteria

STUDY GROUP AIntubation will be done with sedoanalgesics and NMBA Vecuronium

STUDY GROUP BIntubation without NMBA Intubation will be with induction agents as per standard guidelines with sedative and analgesics

EXPECTED DURATION OF THE STUDY is18 months

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
1.00 Day(s) 至 14.00 Year(s)(—)
性别
All

入选标准

  • Children of age group between 1month to 14 years presenting to Paediatric emergency planned for intubation.

排除标准

  • Anticipated Difficult airway (anatomical)
  • Syndromic children
  • Children with neuromuscular disorders
  • Children with crush injuries
  • History of anaphylaxis to any NMBA.

结局指标

主要结局

To assess the Role of Neuromuscular Blocking Agent, Vecuronium in improving the first pass success of intubation in Pediatric emergency

时间窗: Baseline during intubation

次要结局

  • 1To compare the ease of ventilation at intubation with without NMBA using a validated score Vibymogensen score(2 To compare the number of intubation attempts with & without NMBA including first pass success)

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

Asha Jyothi Penugonda

AIIMS, Raipur

研究点 (1)

Loading locations...

相似试验